Effects of internalized gold nanoparticles with respect to cytotoxicity and invasion activity in lung cancer cells

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Liu, Zhengxia ^a   Wu, Yucheng ^a   Guo, Zhirui ^a   Liu, Ying ^a   Shen, Yujie ^a   Zhou, Ping ^a   Lu, Xiang ^a  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; GOLD NANOPARTICLE; INTERCELLULAR ADHESION MOLECULE 1; CITRIC ACID; GOLD; METAL NANOPARTICLE;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER THERAPY; CELL CYCLE; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER CELL LINE; NANOMEDICINE; PARTICLE SIZE; PROTEIN EXPRESSION; REGULATORY MECHANISM; CELL CYCLE CHECKPOINT; CELL MOTION; CHEMISTRY; DRUG EFFECTS; ENDOCYTOSIS; LUNG TUMOR; METABOLISM; TUMOR CELL LINE; ULTRASTRUCTURE;

APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CITRIC ACID; ENDOCYTOSIS; GOLD; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; METAL NANOPARTICLES; PARTICLE SIZE;

EID: 84902490409     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099175     Document Type: Article

References (38)

1. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD (2005) Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1: 325-327. (Pubitemid 43951781)
2. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, et al. (2005) Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 21: 10644-10654. (Pubitemid 41692144)
3. Dreaden EC, Alkilany AM, Huang X, Murphy CJ, El-Sayed MA (2012) The golden age: gold nanoparticles for biomedicine. Chem Soc Rev 41: 2740-2779.
4. El-Sayed IH, Huang X, El-Sayed MA (2005) Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett 5: 829-834. (Pubitemid 40749040)
5. Weissleder R (2006) Molecular imaging in cancer. Science 312: 1168-1171.
6. Veiseh O, Gunn JW, Kievit FM, Sun C, Fang C, et al. (2009) Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small 5: 256-264.
7. Huang X, Jain PK, El-Sayed IH, El-Sayed MA (2007) Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond) 2: 681-693. (Pubitemid 350268247)
8. Dreaden EC, Mackey MA, Huang X, Kang B, El-Sayed MA (2011) Beating cancer in multiple ways using nanogold. Chem Soc Rev 40: 3391-3404.
9. Giljohann DA, Seferos DS, Daniel WL, Massich MD, Patel PC, et al. (2010) Gold nanoparticles for biology and medicine. Angew Chem Int Ed Engl 49: 3280-3294.
10. Arvizo RR, Rana S, Miranda OR, Bhattacharya R, Rotello VM, et al. (2011) Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge. Nanomedicine 7: 580-587.
11. Alkilany AM, Murphy CJ (2010) Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res 12: 2313-2333.
12. Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, et al. (2009) Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 5: 2067-2076.
13. Chithrani BD, Ghazani AA, Chan WC (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6: 662-668.
14. Eccles SA, Box C, Court W (2005) Cell migration/invasion assays and their application in cancer drug discovery. Biotechnol Annu Rev 11: 391-421. (Pubitemid 41510285)
15. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83: 584-594. (Pubitemid 351720831)
16. Manegold C (2001) Chemotherapy for advanced non-small cell lung cancer: standards. Lung Cancer 34 Suppl 2: S165-170.
17. Ju D, Sun D, Xiu L, Meng X, Zhang C, et al. (2012) Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells. Med Oncol 29: 91-99.
18. Han S, Ritzenthaler JD, Sitaraman SV, Roman J (2006) Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281: 29614-29624. (Pubitemid 44536969)
19. Dowlati A, Gray R, Sandler AB, Schiller JH, Johnson DH (2008) Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab-an Eastern Cooperative Oncology Group Study. Clin Cancer Res 14: 1407-1412. (Pubitemid 351413922)
20. Li Y, Liang J, Liu X, Liu H, Yin B, et al. (2012) Correlation of polymorphisms of the vascular endothelial growth factor gene and the risk of lung cancer in an ethnic Han group of North China. Exp Ther Med 3: 673-676.
21. Fajersztajn L, Veras M, Barrozo LV, Saldiva P (2013) Air pollution: a potentially modifiable risk factor for lung cancer. Nat Rev Cancer 13: 674-678.
22. Slot JW, Geuze HJ (1985) A new method of preparing gold probes for multiple-labeling cytochemistry. Eur J Cell Biol 38: 87-93. (Pubitemid 15045723)
23. Frens G (1973) Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature 241: 20-22.
24. Coulter JA, Jain S, Butterworth KT, Taggart LE, Dickson GR, et al. (2012) Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles. Int J Nanomedicine 7: 2673-2685.
25. Tsai SW, Liaw JW, Kao YC, Huang MY, Lee CY, et al. (2013) Internalized gold nanoparticles do not affect the osteogenesis and apoptosis of MG63 osteoblast-like cells: a quantitative, in vitro study. PLoS One 8: e76545.
26. Arvizo R, Bhattacharya R, Mukherjee P (2010) Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin Drug Deliv 7: 753-763.
27. Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 3: 703-717.
28. Patra HK, Banerjee S, Chaudhuri U, Lahiri P, Dasgupta AK (2007) Cell selective response to gold nanoparticles. Nanomedicine 3: 111-119. (Pubitemid 46899618)
29. Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, et al. (2003) Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3: 589-601. (Pubitemid 36808653)
30. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70. (Pubitemid 30046295)
31. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174. (Pubitemid 37328786)
32. Pritchard SC, Nicolson MC, Lloret C, McKay JA, Ross VG, et al. (2001) Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: implications for MMP inhibition therapy. Oncol Rep 8: 421-424. (Pubitemid 33758105)
33. Guo CB, Wang S, Deng C, Zhang DL, Wang FL, et al. (2007) Relationship between matrix metalloproteinase 2 and lung cancer progression. Mol Diagn Ther 11: 183-192. (Pubitemid 46983410)
34. Hung WC, Tseng WL, Shiea J, Chang HC (2010) Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett 288: 156-161.
35. Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, et al. (2009) Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF). Cancer Lett 285: 127-133.
36. Lin YC, Shun CT, Wu MS, Chen CC (2006) A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappaB. Clin Cancer Res 12: 7165-7173.
37. Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, et al. (2005) Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 26: 943-950. (Pubitemid 41214323)
38. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, et al. (2005) Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 11: 3530-3534. (Pubitemid 40627908)